Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Purdue Pharma LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3323
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives (for sleep disorders), laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates three facilities in North Carolina and New Jersey. It is a member of MundiPharma International Limited’s network of independent associated companies. Purdue is headquartered in Stamford, Connecticut, the US.

Purdue Pharma LP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12
Venture Financing 13
Kolltan Pharma Raises US$60 Million In Series D Financing 13
Partnerships 15
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17
Purdue Pharma to Form Joint Venture with AnaBios 18
Eisai Enters into Agreement with Purdue Pharma 19
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 21
Licensing Agreements 22
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 22
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 23
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 24
Purdue Pharma Enters into Licensing Agreement with Exicure 25
Purdue Pharma Enters into Licensing agreement with AnaBios 26
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 27
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 28
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 29
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 30
Purdue Pharma LP – Key Competitors 31
Purdue Pharma LP – Key Employees 32
Purdue Pharma LP – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Corporate Communications 34
Jul 24, 2018: Purdue Pharma announces leadership changes 34
Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer 36
Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P. 37
Legal and Regulatory 38
Aug 02, 2018: Orland Fire joins 13 municipalities in class action suit to block Opioid addiction 38
Jun 12, 2018: Mass. Sues Purdue Pharma over 670 residents who fatally overdosed on opioids 39
Jun 08, 2018: Tenn. Attorney General Seeks to Make State’s Complaint against Purdue Pharma Public 40
Feb 06, 2018: Beasley Allen files opioid lawsuit on behalf of the State of Alabama 41
May 31, 2017: Attorney General DeWine Files Lawsuit Against Opioid Manufacturers for Fraudulent Marketing; Fueling Opioid Epidemic 42
Government and Public Interest 43
Feb 09, 2018: Purdue Pharma Issues Statement on Opioid Promotion 43
Jan 31, 2018: Purdue Pharma L.P. Awards Grants to Further Research on the Assessment of Chronic Pain 44
Product News 45
Jun 12, 2017: Consumer Research Drives New Packaging Updates for Colace and Senokot Occasional Constipation Relief Products 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Purdue Pharma LP, Pharmaceuticals & Healthcare, Key Facts 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Purdue Pharma LP, Deals By Therapy Area, 2012 to YTD 2018 9
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12
Kolltan Pharma Raises US$60 Million In Series D Financing 13
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17
Purdue Pharma to Form Joint Venture with AnaBios 18
Eisai Enters into Agreement with Purdue Pharma 19
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 21
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 22
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 23
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 24
Purdue Pharma Enters into Licensing Agreement with Exicure 25
Purdue Pharma Enters into Licensing agreement with AnaBios 26
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 27
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 28
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 29
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 30
Purdue Pharma LP, Key Competitors 31
Purdue Pharma LP, Key Employees 32
Purdue Pharma LP, Other Locations 33
Purdue Pharma LP, Subsidiaries 33

List of Figures
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Lion Group:企業の戦略・SWOT・財務情報
    The Lion Group - Strategy, SWOT and Corporate Finance Report Summary The Lion Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Barry Callebaut AG:企業のM&A・事業提携・投資動向
    Barry Callebaut AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barry Callebaut AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • Phoenix Pharmahandel GmbH & Co KG:企業の戦略的SWOT分析
    Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Greencore Group Plc:企業のM&A・事業提携・投資動向
    Greencore Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Greencore Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析
    Summary Pluristem Therapeutics Inc (Pluristem) is a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administered to patients without tissue or genetic matching. The compan …
  • Barracuda Networks, Inc.:企業の戦略・SWOT・財務情報
    Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Laborie Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Cypress Energy Partners LP (CELP):企業の財務・戦略的SWOT分析
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • Ergon, Inc.:石油・ガス:M&Aディール及び事業提携情報
    Summary Ergon Inc (Ergon) is an integrated energy company that carries out the exploration and production of crude oil and natural gas, processing, transportation and terminaling of crude oil, storage, marketing and distribution of specialty petroleum products. The company also manufactures and mark …
  • Partner Reinsurance Asia Pte. Ltd.:企業の戦略・SWOT・財務分析
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Air China Limited:戦略・SWOT・企業財務分析
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Columbus McKinnon Corp (CMCO):企業の財務・戦略的SWOT分析
    Summary Columbus McKinnon Corp (CMCO) is an industrial equipment company that offers cranes and hoists. The company designs, manufactures and markets material handling systems and services, which are used for moving, lifting, positioning and securing materials. Its products include hoists, actuators …
  • Bharat Heavy Electricals Ltd (BHEL):電力:M&Aディール及び事業提携情報
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Black & Veatch Corp:企業の戦略的SWOT分析
    Black & Veatch Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Anadolubank A.S.:企業の戦略・SWOT・財務情報
    Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆